Filing Flows › ProPhase Labs (PRPH) › Q1 2025
ProPhase Labs (PRPH) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 20, 2025
ProPhase Labs (PRPH) reported revenue of $1.4M for the first quarter 2025 (Q1 2025), -39% from a year earlier. Operating margin was -256.0%, net earnings $4.0M (277.1% of revenue).
ProPhase Labs, Q1 2025: revenue $1.4M (-39% year over year), operating margin -256.0%, net earnings $4.0M, operating cash flow −$3.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | — | -39% |
| Operating profit | −$3.7M | — | — |
| Net earnings | $4.0M | — | — |
| Operating cash flow | −$3.4M | — | — |
What changed
Revenue was $1.4M in Q1 2025, down 39% year over year.
Gross margin was 36.8%. Operating costs exceeded revenue by $3.7M, an operating margin of -256.0%. Net earnings were $4.0M. The effective tax rate was 0.0%. Non-operating items added $7.6M, 192% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$3.4M. Non-cash charges added back $1.5M of depreciation and amortization and $521K of share-based compensation. Working capital and other items used $9.3M.
Questions
What was ProPhase Labs' revenue in the first quarter 2025?
ProPhase Labs (PRPH) reported revenue of $1.4M for the first quarter 2025 (Q1 2025), -39% from a year earlier.
Was ProPhase Labs profitable in the first quarter 2025?
Operating loss was $3.7M (-256.0% of revenue) and net earnings $4.0M.
Source: ProPhase Labs 10-Q on SEC EDGAR.